Study Comparing Paclitaxel Plus Carboplatin Versus Anthracyclines Followed by Docetaxel as Adjuvant Chemotherapy for Triple Negative Breast Cancer (PATTERN)

NCT04031703 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

647

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Paclitaxel
DRUG: Carboplatin
DRUG: Epirubicin
DRUG: Cyclophosphamide
DRUG: 5-fluorouracil
DRUG: Docetaxel

Sponsor

Fudan University